Trials
Search / Trial NCT05642104

The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy

Launched by BEIJING SHIJITAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY · Dec 6, 2022

Trial Information

Current as of January 13, 2025

Unknown status

Keywords

Breast Neoplasms Cell In Cell Structures Neoadjuvant Therapy

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age 18-65, female;
  • Pathological biopsy confirmed invasive ductal carcinoma;
  • Karnofsky Performance Status (KPS)≥ 60, expected survival ≥4 months;
  • Locally advanced breast cancer (HER2-positive disease and TNBC, ≥cT1c or ≥cN0; HER2-negative,HR positive disease,≥cT2 or ≥cN1;Large primary tumor relative to breast size in a patient who desires breast conservation) ;
  • According to the RECIST1.1 standard, at least one measurable lesion exists;
  • Exclusion Criteria:
  • Pregnant or lactating women;
  • Left ventricular ejection fraction less than 50%;
  • History of malignant tumor and concurrent occurrence of other tumors;
  • Serious medical pathology, such as congestive heart failure; unstable angina; uncontrolled high risk arrhythmias, and other serious illness or medical condition that may interfere with the study;
  • Refuse to participate in the study.

Trial Officials

Hongyan Huang, PHD

Principal Investigator

Beijing Shijitan Hospital, Capital Medical University

About Beijing Shijitan Hospital, Capital Medical University

Beijing Shijitan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care and a multidisciplinary approach, the hospital is dedicated to conducting high-quality clinical trials that contribute to the understanding and treatment of various medical conditions. Leveraging its extensive network of healthcare professionals and state-of-the-art facilities, Beijing Shijitan Hospital plays a pivotal role in fostering medical advancements and improving therapeutic outcomes through rigorous scientific investigation and collaboration within the global research community.

Locations

Beijing, Beijing, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials